|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 47/68 | (2017.01) |
| C07K 16/28 | (2006.01) | ||
| A61P 35/00 | (2006.01) |
| (11) | Number of the document | 3055332 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14852834.2 |
| Date of filing the European patent application | 2014-10-08 | |
| (97) | Date of publication of the European application | 2016-08-17 |
| (45) | Date of publication and mention of the grant of the patent | 2019-09-25 |
| (46) | Date of publication of the claims translation | 2019-12-27 |
| (86) | Number | PCT/US2014/059716 |
| Date | 2014-10-08 |
| (87) | Number | WO 2015/054400 |
| Date | 2015-04-16 |
| (30) | Number | Date | Country code |
| 201361888337 P | 2013-10-08 | US | |
| 201361888365 P | 2013-10-08 | US | |
| 201461948363 P | 2014-03-05 | US | |
| 201462004815 P | 2014-05-29 | US |
| (72) |
LUTZ, Robert J., US
PONTE, Jose, US
|
| (73) |
ImmunoGen, Inc.,
830 Winter Street, Waltham, MA 02451-1477,
US
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Anti-FOLR1 imunokonjugato dozavimo režimai |
| ANTI-FOLR1 IMMUNOCONJUGATE DOSING REGIMENS |
| Payment date | Validity (years) | Amount | |
| 2025-09-16 | 12 | 289.00 EUR |
| 2026-10-08 |